STREESCO

Durada

01/12/2020 - 31/05/2022

Coordinador

Institut de Recherche Clinique du Bénin

Finançadors

EDCTP (Project code: RIA2020EF-2923)

Pàgina web

https://streesco.org/

The COVID-19 pandemic has shown that delayed detection of cases and clusters, a lack of awareness of the rate of spread, a high spatial extent of the pandemic, and a too weak response during the alert phase weigh heavily on the evolution of the pandemic. Sub-Saharan African countries need to generate data on COVID-19 dynamics, on the demand for care in primary health facilities and hospitals, and on the needs for health care and protective equipment and therapeutics in order to establish adequate measures.

As part of the health systems set up by Benin and Burkina Faso's health authorities, the project will develop with intended users epidemic surveillance and response system that will be effective, sensitive, coordinated, and adapted to a low-resource context. The epidemic surveillance system will be able to produce and process the ongoing information needed to execute early alerts and to control the health system's response.

The information system will be based on field epidemiological investigations, virological tests, and indicators that track action, monitoring adaptation to the epidemic, and control the response capabilities of health structures. The analysis of the data collected will bring knowledge useful for a better understanding of the epidemic dynamics. Finally, the project will promote African and European research collaboration and strengthen the capacity of African institutions to conduct an epidemic surveillance system.

The project is coordinated by the Institut de Recherche Clinique du Bénin (IRCB) and the Institut de Recherche pour le Développement (IRD) from France. ISGlobal is the lead research organization responsible for implementing the Networking and Dissemination activities of the STREESCO project. Networking activities will be horizontal and will occur internally among project partners and externally with other COVID-19 consortia.

Total Funding

499.994,50 €